Back
ESC2025 Premium Access

Acoramidis-mediated improvement in NT-proBNP at month 30 compared with placebo in patients with ATTR-CM: results from the ATTRibute-CM study

Session: Cardiac amyloidosis
Topic: Infiltrative Myocardial Disease
Speaker: Doctor N. Sarswat (Chicago, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Nitasha Sarswat

University of Chicago Medical Center, Chicago (United States of America)
3 presentations
0 follower

4 more presentations in this session

Pyrophosphate scintigram as a potential imaging index of therapeutic efficacy for transthyretin cardiac amyloidosis

Speaker: Mr S. Saito (Shimotsuke, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Two-year cardiac follow-up of transthyretin amyloid deposition in surgical specimens from carpal tunnel syndrome and rotator cuff tear cases

Speaker: Assistant Professor T. Umemoto (Tokyo, JP)

Access
Abstract
Slides
Like
Thumbnail

Spatial transcriptomics of human cardiac biopsy samples reveals gene expression signature of cardiac amyloidosis

Speaker: Mr S. Saito (Shimotsuke, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Cardiac transthyretin amyloidosis in patients with conduction system disease

Speaker: Doctor J. Pudich (Ostrava, CZ)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiac amyloidosis

Speakers: Doctor N. Sarswat, Mr S. Saito, Assistant Professor T. Umemoto, Mr S. Saito, Doctor J. Pudich
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources